Clinical Trial Update: Atrial Fibrillation Trial To Eliminate Risk-factors

View source ↗

Summary

Atrial fibrillation risk-factor elimination trial sponsored by National Taiwan University Hospital has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Atrial Fibrillation | Status: COMPLETED